Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 10/20 | 0.49 |
| ▸ | ACHE | P22303 | 8/20 | 0.49 |
| ▸ | EGFR | P00533 | 1/20 | 0.48 |
| ▸ | ICMT | O60725 | 2/20 | 0.47 |
| ▸ | ALB | P02768 | 2/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.43 |
| ▸ | DRD2 | P14416 | 1/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | DRD3 | P35462 | 1/20 | 0.43 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21990529 | 1.00 | BCHE (0.49) | BCHEACHEEGFRICMTALB | |
| SCHEMBL4016548 | 0.94 | BCHE (0.50) | BCHEACHEEGFRDRD2OPRM1 | |
| SCHEMBL7949065 | 0.90 | EGFR (0.47) | BCHEACHEEGFR | |
| Tetrabuthylammonium SCHEMBL5893078 | 0.82 | EGFR (0.47) | EGFR | |
| SCHEMBL8685616 | 0.82 | DNM1 (0.48) | EGFRKCNH2DRD2DRD3OPRK1 | |
| SCHEMBL9548468 | 0.82 | DNM1 (0.48) | EGFRKCNH2DRD2DRD3OPRK1 | |
| SCHEMBL5274183 | 0.82 | EGFR (0.47) | EGFRKCNH2DRD2DRD3OPRK1 | |
| SCHEMBL7945375 | 0.82 | NPC1 (0.47) | BCHEACHE | |
| SCHEMBL28285936 | 0.81 | EGFR (0.48) | EGFR | |
| Alcohol SCHEMBL29033352 | 0.80 | HTT (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11459410-B2 | High-purity amphipathic arylsulfonic acid amine salt vinyl monomer and copolymer thereof | TOSOH FINECHEM CORPORATION (JP) | 2022-10-04 | — | — | US | disclosed |
| CN-110997631-B | High purity amphiphilic arylsulfonic acid amine salt vinyl monomers and (co) polymers thereof | 东曹精细化工株式会社 | 2022-07-15 | — | — | CN | disclosed |
| EP-3666753-A1 | HIGH-PURITY AMPHIPATHIC ARYLSULFONIC ACID AMINE SALT VINYL MONOMER AND COPOLYMER THEREOF | Tosoh Finechem Corporation (JP) | 2020-06-17 | — | — | EP | disclosed |
| US-20200172643-A1 | HIGH-PURITY AMPHIPATHIC ARYLSULFONIC ACID AMINE SALT VINYL MONOMER AND COPOLYMER THEREOF | TOSOH FINECHEM CORPORATION (JP) | 2020-06-04 | — | — | US | disclosed |
| CN-110997631-A | High purity amphiphilic arylsulfonic acid amine salt vinyl monomers and (co) polymers thereof | 东曹精细化工株式会社 | 2020-04-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11459410-B2 | High-purity amphipathic arylsulfonic acid amine salt vinyl monomer and copolymer thereof | SLC7A1, ARSA, STS | BCHE 3885/4885ACHE 4621/4885EGFR 628/4885 |
| US-20200172643-A1 | HIGH-PURITY AMPHIPATHIC ARYLSULFONIC ACID AMINE SALT VINYL MONOMER AND COPOLYMER THEREOF | SLC7A1, ARSA, STS | BCHE 3885/4885ACHE 4621/4885EGFR 628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.